Acadia Healthcare expands board to nine with independent director Mike Fucci
Mike Fucci joined Acadia Healthcare’s board in October 2020, bringing decades of leadership experience from Deloitte to the behavioral health provider’s governance ranks.
Acadia Healthcare (Nasdaq: ACHC), headquartered in Franklin, Tennessee, expanded its board to nine members with the addition of the former Deloitte U.S. chairman as an independent director. The company operates 582 facilities across 40 states, the United Kingdom and Puerto Rico, including inpatient psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics.
Fucci retired from Deloitte in September 2020 after a long tenure in senior roles. He served as Executive Chairman of Deloitte U.S. from 2015 to 2019 and as Chairman Emeritus until his retirement. Earlier, he was Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and a member of Deloitte’s U.S. Board of Directors since 2013. His global service included a seat on the Deloitte Global Board of Directors beginning in 2015, where he participated on governance and compensation committees.
Throughout his career, Fucci focused on strategy, leadership succession, risk mitigation and talent development. He established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors that addresses research and trends affecting corporate governance. He also chaired the Deloitte Foundation, overseeing education-focused philanthropic initiatives.
Acadia’s board chairman, Reeve Waud, emphasized the strategic fit in a statement announcing the appointment. “[Fucci] brings a unique perspective on human resource transformation, corporate talent strategies and risk mitigation that will complement the work and expertise of our other directors,” Waud said. “We look forward to his valuable contributions as we execute our growth strategy and pursue our primary objective to deliver long-term value for our stockholders.”
As Acadia pursues expansion and operational stability in a complex regulatory and clinical environment, the addition of Fucci is positioned to strengthen oversight in areas critical to large health-care operators—risk assessment, executive performance evaluation and human capital strategy. Investors and governance observers will likely watch how Fucci’s corporate governance credentials influence Acadia’s board deliberations and long-term strategic planning.
Follow: https://x.com/fucci_mike
